Health Care: Drugs

Johnson & Johnson (JNJ: NYSE)

$115.63 n/a | n/a%
06/24/16 - 04:01 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 70.07B 74.33B 71.31B 67.22B
Cost of Sales 17.79B 18.85B 18.24B 17.99B
Gross Operating Profit 52.28B 55.48B 53.07B 49.23B
Selling, General, and Administrative Expenses 21.20B 21.95B 21.83B 20.87B
Research & Development 9.05B 8.67B 8.18B 7.67B
Operating Income before D & A (EBITDA) 22.04B 24.85B 23.06B 20.70B
Depreciation & Amortization 3.75B 3.90B 4.10B 3.67B
Interest Income 128.00M 67.00M 74.00M 64.00M
Other Income - Net 1.55B 70.00M -2.50B -1.63B
Special Income / Charges -448.00M 0.00 -1.16B -2.33B
Total Income Before Interest Expenses (EBIT) 19.75B 21.10B 15.95B 14.31B
Interest Expense 552.00M 533.00M 482.00M 532.00M
Pre-Tax Income 19.20B 20.56B 15.47B 13.78B
Income Taxes 3.79B 4.24B 1.64B 3.26B
Minority Interest 0.00 0.00 0.00 -339.00M
Net Income From Continuing Operations 15.41B 16.32B 13.83B 10.51B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 15.41B 16.32B 13.83B 10.51B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 15.41B 16.32B 13.83B 10.85B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
15.63B 16.32B 14.41B 11.68B
Preferred Dividends
Net Income Available To Common 15.41B 16.32B 13.83B 10.51B
Basic EPS from Continuing Ops. 5.56 5.80 4.92 3.94
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 5.56 5.80 4.92 3.94
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 5.56 5.80 4.92 3.94
Basic Normalized Net Income/Share 5.64 5.80 5.13 4.38
EPS fr Continuing Ops. 5.48 5.70 4.81 3.86
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 5.48 5.70 4.81 3.86
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 5.48 5.70 4.81 3.86
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.56 5.70 5.01 4.29
Dividends Paid per Share 2.95 2.76 2.59 2.40

Portfolios with JNJ

Latest JNJ Headlines from TheStreet

More Financial News for JNJ

Press Releases for JNJ

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter